Identification of novel variants in hereditary spherocytosis patients by whole-exome sequencing

IF 3.2 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Clinica Chimica Acta Pub Date : 2024-10-06 DOI:10.1016/j.cca.2024.119989
Li Qin , Yujiao Jia , Haoxu Wang , Yuan Feng , Junyan Zou , Jianfeng Zhou , Changshun Yu , Bingqing Huang , Ruixue Zhang , Lihui Shi , Jigang Xiao , Yuping Zhao , Qi Sun , Zhijian Xiao , Huijun Wang
{"title":"Identification of novel variants in hereditary spherocytosis patients by whole-exome sequencing","authors":"Li Qin ,&nbsp;Yujiao Jia ,&nbsp;Haoxu Wang ,&nbsp;Yuan Feng ,&nbsp;Junyan Zou ,&nbsp;Jianfeng Zhou ,&nbsp;Changshun Yu ,&nbsp;Bingqing Huang ,&nbsp;Ruixue Zhang ,&nbsp;Lihui Shi ,&nbsp;Jigang Xiao ,&nbsp;Yuping Zhao ,&nbsp;Qi Sun ,&nbsp;Zhijian Xiao ,&nbsp;Huijun Wang","doi":"10.1016/j.cca.2024.119989","DOIUrl":null,"url":null,"abstract":"<div><div>Defects in erythrocyte membrane proteins can cause the most common type of inherited hemolytic anemia, so called hereditary spherocytosis (HS). It is characterized by the appearance of spherocytes in peripheral blood, hemolytic anemia, splenomegaly, jaundice and gallstones. Due to difficulty of diagnosis solely based on aforementioned parameters, the addition of genetic testing seems to be effective and most acknowledged. Up to date, pathogenic variations in five genes encoding membrane proteins (<em>ANK1</em>, <em>SPTA1</em>, <em>SPTB</em>, <em>SLC4A1</em>, <em>EPB42</em>) are identified to cause HS. Here, we have studied the genetic spectrum in forty-one patients with clinically suspected HS and their families, as well as their genotype-phenotype correlations. Pathogenic mutations in <em>ANK1</em>, <em>SPTB</em>, <em>SLC4A1</em> and <em>SPTA1</em> were found in 17 (41.5 %), 12 (29.3 %), 7 (17.1 %) and 5 (12.2 %) patients, respectively. Deleterious variants include 12 missense, 15 nonsense, 12 frameshift, and 4 splicing variants. Among these variations 32 were novel. In our genotype-phenotype analysis, platelet levels in <em>SPTB</em> (p = 0.021) and <em>SLC4A1</em> (p = 0.02) patients were found to be significantly lower than <em>ANK1</em> patients. In addition, LDH levels in <em>SPTB</em> patients were remarkably lower than patients with <em>ANK1</em> mutations (p = 0.025).</div></div>","PeriodicalId":10205,"journal":{"name":"Clinica Chimica Acta","volume":"565 ","pages":"Article 119989"},"PeriodicalIF":3.2000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Chimica Acta","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009898124022423","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Defects in erythrocyte membrane proteins can cause the most common type of inherited hemolytic anemia, so called hereditary spherocytosis (HS). It is characterized by the appearance of spherocytes in peripheral blood, hemolytic anemia, splenomegaly, jaundice and gallstones. Due to difficulty of diagnosis solely based on aforementioned parameters, the addition of genetic testing seems to be effective and most acknowledged. Up to date, pathogenic variations in five genes encoding membrane proteins (ANK1, SPTA1, SPTB, SLC4A1, EPB42) are identified to cause HS. Here, we have studied the genetic spectrum in forty-one patients with clinically suspected HS and their families, as well as their genotype-phenotype correlations. Pathogenic mutations in ANK1, SPTB, SLC4A1 and SPTA1 were found in 17 (41.5 %), 12 (29.3 %), 7 (17.1 %) and 5 (12.2 %) patients, respectively. Deleterious variants include 12 missense, 15 nonsense, 12 frameshift, and 4 splicing variants. Among these variations 32 were novel. In our genotype-phenotype analysis, platelet levels in SPTB (p = 0.021) and SLC4A1 (p = 0.02) patients were found to be significantly lower than ANK1 patients. In addition, LDH levels in SPTB patients were remarkably lower than patients with ANK1 mutations (p = 0.025).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过全外显子组测序鉴定遗传性球形红细胞增多症患者的新型突变。
红细胞膜蛋白质缺陷可导致最常见的遗传性溶血性贫血,即遗传性球形红细胞增多症(HS)。其特征是外周血中出现球形细胞、溶血性贫血、脾肿大、黄疸和胆结石。由于仅根据上述参数难以确诊,增加基因检测似乎是最有效和最被认可的方法。迄今为止,已发现五个编码膜蛋白的基因(ANK1、SPTA1、SPTB、SLC4A1、EPB42)的致病变异可导致 HS。在此,我们研究了 41 例临床疑似 HS 患者及其家族的基因谱,以及他们的基因型与表型之间的相关性。在 17 例(41.5%)、12 例(29.3%)、7 例(17.1%)和 5 例(12.2%)患者中分别发现了 ANK1、SPTB、SLC4A1 和 SPTA1 的致病突变。致畸变异包括 12 个错义变异、15 个无义变异、12 个框移变异和 4 个剪接变异。这些变异中有 32 个是新变异。在我们的基因型-表型分析中,发现 SPTB(p = 0.021)和 SLC4A1(p = 0.02)患者的血小板水平明显低于 ANK1 患者。此外,SPTB 患者的 LDH 水平明显低于 ANK1 突变患者(p = 0.025)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinica Chimica Acta
Clinica Chimica Acta 医学-医学实验技术
CiteScore
10.10
自引率
2.00%
发文量
1268
审稿时长
23 days
期刊介绍: The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells. The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal''s scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
期刊最新文献
Corrigendum to "Irisin in thyroid diseases" [Clin. Chim. Acta 564 (2025) 119929]. Steroid hormone concentrations in dried blood spots: A comparison between capillary and venous blood samples. A nomogram model for predicting advanced liver fibrosis in patients with hepatitis B: A multicenter study. Recommendations for assessing commutability of a replacement batch of a secondary calibrator certified reference material. Advances in laboratory diagnosis of Sjogren's disease in children.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1